Visual Gains With Aflibercept Upheld at 52 Weeks in VIBRANT

For macular edema secondary to branch retinal vein occlusion, visual benefit is greater with monthly intravitreal aflibercept injections than with laser therapy, the latest data confirm.
Medscape Medical News